MetaCap

Biote (BTMD) vs Ispire Technology (ISPR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Ispire Technology (ISPR) has outperformed Biote (BTMD) over the past year, losing 43.6% versus a loss of 68.9%. Ispire Technology is the larger company by market cap ($71.1 million vs $26.3 million), about 2.7 times the size, while Biote is growing revenue faster (-2.5% vs -24.7%). Biote converts more of its revenue into profit, with a net margin of 14.1% versus -34.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BTMD-68.90%ISPR-43.58%
+76%-0%-76%
Nov 21, 20251 yearNov 20, 2026
BTMD-86.19%ISPR-82.63%
+85%-5%-94%
Apr 3, 20235 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BTMD versus ISPR key metrics
MetricBTMDISPR
Share price$0.8147$1.23
Market cap$26.28M$71.05M
1-day change-3.56%-3.15%
YTD return-68.67%-56.07%
1-year return-68.90%-43.58%
5-year return-91.64%—
Forward P/E3.33—
EPS (TTM)$-0.07$-0.64
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$192.22M$96.01M
Revenue growth (YoY)-2.52%-24.69%
Net income (latest FY)$27.05M$-33.20M
Gross margin71.46%12.81%
Operating margin18.50%-33.95%
Net margin14.07%-34.58%
52-week high$2.90$3.87
52-week low$0.81$1.01
Distance from 52-week high-71.91%-68.22%
Analyst consensusnonestrong_buy
Avg. price target upside+220.36%+298.37%
Average volume146.21K20.51K
Shares outstanding27.04M57.77M
Employees22388
SectorHealth CareHealth Care
Industry Medicinal Chemicals and Botanical Products Medicinal Chemicals and Botanical Products

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Ispire Technology is about 2.7 times larger than Biote by market value ($71.05M vs $26.28M).
  • ISPR has outperformed BTMD by 25.3 percentage points over the past year.
  • Biote is more profitable, keeping 14.1 cents of every revenue dollar as net income versus -34.6 cents for Ispire Technology.
  • Biote grew revenue faster in its latest fiscal year (-2.52% vs -24.69%).

About Biote

BTMD stock →

biote Corp. operates in practice-building business within the hormone optimization space.

Health Care · Medicinal Chemicals and Botanical Products · 223 employees

About Ispire Technology

ISPR stock →

Ispire Technology Inc. researches, develops, designs, commercializes, sells, markets, and distributes e-cigarettes and cannabis vaping products worldwide under the Aspire brands.

Health Care · Medicinal Chemicals and Botanical Products · 88 employees

BTMD vs ISPR FAQ

Which is bigger, Biote or Ispire Technology?

Ispire Technology (ISPR) is larger, with a market capitalization of $71.05M compared with $26.28M for Biote (BTMD).

Which stock has performed better over the past year, BTMD or ISPR?

ISPR returned -43.58% over the past 12 months, compared with -68.90% for BTMD (price return, excluding dividends). Past performance does not predict future results.

Are Biote and Ispire Technology in the same industry?

Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.

More comparisons